Anti-Obesity Drugs Market In-Depth Analysis By
2026
Anti-obesity Drugs are pharmacological agents that reduce or control the weight. These drugs
change one of the fundamental processes of human body, weight regulation, either by changing
the absorption of calories or dipping the hunger. Appetite control is achieved by using the
agonists for appetite suppressing pathways. Various anti-obesity drugs, which are approved from
the past decade such as knoll and acomplia (romonabant) are removed, as they cause suicidal
thoughts, depression, and cardiovascular problems, due to their long-term usage.
Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/2824
Global Anti-Obesity Drugs Market- Dynamics
Increasing prevalence of obesity, adoption of deskbound lifestyle, increasing geriatric population,
and chronic nature of disease is expected to augment market growth. Furthermore, faulty eating
habits and rising consumption of fast food coupled with lack exercise is driving the market
globally. In October 2018, Novo Nordisk launched new obesity treatment on world obesity day.
The company announced the availability of Saxenda in Singapore, which is a Health Sciences
Authority (HSA) approved injectable medicine that is used with low calorie meal plan and helps
the adults who are obese or who are overweight with at least one weight associated medical
problem to lose weight.
Basic activities such reducing the intake of unhealthy food and inculcating workout are not seen
to be highly effective, and the medical devices such as intragastric balloon and bariatric surgery
have complications and are highly expensive. All this shows difficulties in treatment of obesity.
These unmet needs are driving growth of global anti-obesity drugs market. For instance, in
September, 2014, the U.S. FDA’s approved a new prescription weight loss pill- Contrave for
obese adults, the new drug is the third prescription weight loss drug approved by the FDA.
Report includes chapters which deeply display the following deliverable about industry :
• Anti-Obesity Drugs Market Research Objective and Assumption
• Anti-Obesity Drugs Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)